Amino Acid Metabolism Practice Questions

Q: Which branched-chain amino acid is the PRIMARY contributor to neurotoxicity in maple syrup urine disease?

Leucine. ***Leucine*** - **Leucine** is the primary branched-chain amino acid (BCAA) responsible for neurotoxicity in **maple syrup urine disease (MSUD)** due to its high concentration in the brain, especially in immature brains. - High levels of leucine and its ketoacid derivative **alpha-ketoisocaproate** interfere with neurotransmitter synthesis, myelin formation, and cerebral energy metabolism, leading to significant neurological damage. *Valine* - While **valine** is one of the BCAAs that accumulates in MSUD, its contribution to direct neurotoxicity is less pronounced compared to leucine. - **Valine** is essential for protein synthesis and tissue repair but does not exert the same level of direct inhibitory effects on cerebral metabolism as leucine. *Isoleucine* - **Isoleucine** is another BCAA whose levels are elevated in MSUD, but it plays a relatively minor role in the acute neurotoxicity compared to leucine. - Its levels must be monitored during dietary treatment of MSUD, as maintaining proper balance of all three BCAAs is essential for preventing metabolic decompensation. *Phenylalanine* - **Phenylalanine** is an aromatic amino acid, not a branched-chain amino acid, and its elevated levels are characteristic of **phenylketonuria (PKU)**, not MSUD. - High phenylalanine causes neurotoxicity in PKU through different mechanisms, distinct from the BCAA-related toxicity seen in MSUD.

Q: Which of the following statements about Carbamoyl Phosphate Synthetase I (CPSI) is true?

N-Acetyl Glutamate is an allosteric activator of CPSI.. ***N-Acetyl Glutamate is an allosteric activator of CPSI.*** - **N-acetylglutamate (NAG)** is an essential allosteric activator for **Carbamoyl Phosphate Synthetase I (CPSI)**, signaling a high availability of arginine and a need for urea cycle activity. - Activation by NAG ensures that ammonia is incorporated into the urea cycle only when necessary, preventing its accumulation which can be toxic. *It is present in the cytoplasm.* - **CPSI** is located exclusively in the **mitochondrial matrix** of hepatocytes, where it initiates the urea cycle by converting ammonia to carbamoyl phosphate. - Its cytosolic counterpart, **CPSII**, is involved in pyrimidine synthesis, which differentiates their cellular locations and metabolic roles. *It is involved in pyrimidine synthesis.* - **CPSI** is the rate-limiting enzyme of the **urea cycle**, responsible for detoxifying ammonia by forming carbamoyl phosphate. - **Carbamoyl Phosphate Synthetase II (CPSII)**, located in the cytosol, is the enzyme involved in **pyrimidine synthesis**. *Glutamine is the amino group donor for CPSI.* - **CPSI** uses **free ammonia** (NH3) and **bicarbonate** as substrates to synthesize carbamoyl phosphate, not glutamine. - **Glutamine** is the nitrogen source for **Carbamoyl Phosphate Synthetase II (CPSII)** in pyrimidine synthesis.

Q: Which enzyme catalyzes the transfer of an α-amino group from aspartate to α-ketoglutarate?

Aspartate Transaminase (AST). ***Aspartate Transaminase (AST)*** - **Aspartate transaminase (AST)**, also known as **glutamic-oxaloacetic transaminase (GOT)**, specifically catalyzes the reversible transfer of an **α-amino group** from an L-amino acid (like **aspartate**) to an α-keto acid (like **α-ketoglutarate**). - This reaction forms a new amino acid and a new α-keto acid; in this case, **oxaloacetate** and **glutamate** are formed. *Ornithine transcarbamylase (OTC)* - **OTC** is an enzyme involved in the **urea cycle**, catalyzing the reaction between **ornithine** and **carbamoyl phosphate** to form citrulline. - It does not catalyze the transfer of an α-amino group from aspartate to α-ketoglutarate. *Argininosuccinate lyase (ASL)* - **ASL**, also part of the **urea cycle**, catalyzes the cleavage of **argininosuccinate** into **arginine** and **fumarate**. - Its function is distinct from transamination reactions involving α-amino and α-keto acids. *Alanine Aminotransferase (ALT)* - **ALT**, also known as **glutamic-pyruvic transaminase (GPT)**, specifically catalyzes the transfer of an **α-amino group** from **alanine** to **α-ketoglutarate**. - While it performs a similar type of transamination, it acts on alanine, not aspartate.

Q: A 3-day-old newborn presents with hyperammonemia in the blood and an unknown inborn error of metabolism. What is the most likely diagnosis?

Urea cycle enzyme deficiency. ***Urea cycle enzyme deficiency*** - **Hyperammonemia** in a newborn is a hallmark of urea cycle disorders, as the urea cycle is essential for detoxifying ammonia. - The rapid onset of symptoms in a **3-day-old newborn** is consistent with severe forms of urea cycle enzyme deficiencies where ammonia rapidly accumulates after the initiation of protein feeding. *Maple syrup urine disease* - This condition involves impaired metabolism of **branched-chain amino acids** (leucine, isoleucine, valine), leading to their accumulation. - While it can cause neurological symptoms, **hyperammonemia** is not its primary or characteristic metabolic derangement; rather, a distinctive **maple syrup odor** in urine is typical. *Organic aciduria* - These disorders result from defects in pathways of **amino acid or fatty acid metabolism**, leading to the accumulation of various organic acids. - While some severe forms can present with metabolic acidosis and neurological symptoms, **hyperammonemia** is usually secondary and less prominent or central to the pathology compared to urea cycle disorders. *Phenylketonuria* - This is a disorder of **phenylalanine metabolism**, leading to excessive accumulation of phenylalanine in the blood. - It primarily causes developmental delay and neurological issues if untreated, but **hyperammonemia** is not a feature of phenylketonuria.

Q: Urea is synthesized in all except:

Brain. ***Brain*** - The brain **does not possess the complete set of enzymes** required for the urea cycle, particularly lacking carbamoyl phosphate synthetase I (CPS I). - Due to the **blood-brain barrier**, the central nervous system maintains a tightly controlled metabolic environment and handles ammonia through alternative pathways (glutamine synthesis). - The brain **does not synthesize urea** and is the most commonly cited answer for organs lacking this capability. *Liver* - The **liver is the primary and main site of urea synthesis** in mammals, essential for detoxifying ammonia produced from amino acid catabolism. - All five enzymes of the **urea cycle** are predominantly expressed in hepatocytes (periportal region). *Kidney* - The kidney possesses some urea cycle enzymes and has **limited capacity for urea synthesis** in certain cell types. - However, its primary role in nitrogen metabolism is **urea excretion** and gluconeogenesis from amino acids, not significant urea production. - The kidney is NOT a major site of urea synthesis. *Spleen* - The **spleen is primarily involved in immune responses** and erythrocyte recycling (hemolysis and iron metabolism). - It **completely lacks the enzymes of the urea cycle** necessary for converting ammonia to urea.

Q: Tyrosine enters gluconeogenesis by forming which substrate

Fumarate. ***Fumarate*** - Tyrosine is both **glucogenic and ketogenic**, producing two products during catabolism. - The glucogenic portion of tyrosine degradation yields **fumarate**, which enters the **citric acid cycle** and can be converted to oxaloacetate, the key substrate for gluconeogenesis. - Tyrosine → Homogentisate → Maleylacetoacetate → **Fumarate + Acetoacetate** (the latter being ketogenic). - Fumarate is subsequently converted to **malate → oxaloacetate → phosphoenolpyruvate**, initiating gluconeogenesis. *Pyruvate* - While pyruvate is an important gluconeogenic substrate, tyrosine does **not directly form pyruvate**. - Amino acids like **alanine, serine, and cysteine** are converted to pyruvate, not tyrosine. - Tyrosine's gluconeogenic pathway proceeds through **fumarate → oxaloacetate**, bypassing pyruvate formation. *Succinyl CoA* - Succinyl CoA is formed from the catabolism of **valine, isoleucine, methionine, and threonine**. - It is a **citric acid cycle intermediate** but not the product of tyrosine degradation. *Alpha-ketoglutarate* - **Glutamate, glutamine, proline, arginine, and histidine** are catabolized to alpha-ketoglutarate. - This is another **citric acid cycle intermediate** but is not formed from tyrosine metabolism. *Citrate* - Citrate is formed from **oxaloacetate and acetyl-CoA** in the citric acid cycle. - It is not a direct product of amino acid catabolism and does not serve as an entry point for gluconeogenesis.

Q: In argininosuccinase deficiency, what should be supplemented to continue the urea cycle ?

Arginine. ***Correct: Arginine*** - **Arginine** supplementation is the primary treatment for argininosuccinase deficiency - Provides the product of the blocked reaction, allowing the urea cycle to continue - Maintains essential arginine levels and enables **nitrogen scavenger pathway** - Accumulated **argininosuccinate** is excreted in urine, removing excess nitrogen - This bypasses the deficient enzyme while facilitating alternative nitrogen disposal *Incorrect: Aspartate* - **Aspartate** combines with citrulline to form argininosuccinate via argininosuccinate synthetase - Supplementing aspartate alone would increase argininosuccinate accumulation without resolving the enzymatic block - Does not provide the end product (arginine) needed to continue the urea cycle - Not part of the primary therapeutic strategy for this deficiency *Incorrect: Citrulline* - **Citrulline** is actually used as adjunct therapy alongside arginine in argininosuccinase deficiency - However, citrulline supplementation alone cannot **continue the urea cycle** because the enzyme block prevents conversion of argininosuccinate to arginine - While it helps generate argininosuccinate for urinary excretion (nitrogen scavenging), it doesn't provide arginine needed for urea formation - **Arginine** remains the primary supplement as it directly supplies the missing product and enables cycle completion *Incorrect: Argininosuccinate* - **Argininosuccinate** accumulates in this deficiency due to the enzyme block - Supplementing the substrate of a deficient enzyme would worsen metabolic accumulation - The therapeutic goal is to facilitate its excretion, not increase its levels - Contraindicated in this condition

Q: Citrullinemia is due to deficiency of?

Argininosuccinate synthase. ***Argininosuccinate synthase*** - **Citrullinemia** is primarily caused by a deficiency in **argininosuccinate synthase (ASS)**, an enzyme crucial for the conversion of **citrulline** and **aspartate** to **argininosuccinate** in the urea cycle. - This deficiency leads to an accumulation of **citrulline** in the blood and urine, resulting in hyperammonemia and neurological symptoms. *Arginase* - A deficiency in **arginase** (also known as argininemia) leads to the accumulation of **arginine**, but not citrulline. - This enzyme is responsible for the final step of the urea cycle, converting **arginine** to **ornithine** and **urea**. *Ornithine transcarbamylase* - A deficiency in **ornithine transcarbamylase (OTC)** is another common urea cycle disorder, but it results in a buildup of **ammonia** and **carbamoyl phosphate**, not citrulline. - OTC catalyzes the conversion of **carbamoyl phosphate** and **ornithine** to **citrulline**. *Argininosuccinate lyase* - A deficiency in **argininosuccinate lyase (ASL)** causes **argininosuccinic aciduria**, characterized by the accumulation of **argininosuccinate** in the blood and urine. - This enzyme is responsible for converting **argininosuccinate** to **arginine** and **fumarate**.

Q: Cabbage-like odour is seen in ?

Tyrosinemia. ***Tyrosinemia*** - **Tyrosinemia type 1 (hereditary tyrosinemia)** leads to the accumulation of toxic metabolites due to a deficiency in **fumarylacetoacetate hydrolase**. - These metabolites, particularly **succinylacetone**, are responsible for the characteristic **cabbage-like (or rancid butter) odor** in urine and sweat. *Alkaptonuria* - This condition is characterized by a deficiency in **homogentisate-1,2-dioxygenase**, leading to the accumulation of **homogentisic acid**. - The urine turns **dark (black)** when exposed to air, but there is no specific odor associated with cabbage. *Phenylketonuria* - PKU results from a deficiency in **phenylalanine hydroxylase**, causing a buildup of **phenylalanine** and its metabolites. - The classic odor in PKU is described as **musty or mousy**, not cabbage-like. *Hartnup disease* - This is a disorder of **amino acid transport** across the intestinal and renal tubules, specifically for neutral amino acids like **tryptophan**. - It does not involve a distinct body or urine odor like the "cabbage-like" smell.

Q: Which amino acid is a precursor for the synthesis of nicotinic acid?

Tryptophan. ***Tryptophan*** - **Tryptophan** is an essential amino acid that serves as a precursor for various vital compounds, including **nicotinic acid** (niacin), serotonin, and melatonin, making it crucial for metabolic pathways. - The conversion of tryptophan to nicotinic acid involves a complex pathway (kynurenine pathway) that results in the synthesis of **NAD+** and **NADP+**, which are coenzymes vital for redox reactions in the body. - Approximately 60 mg of tryptophan can be converted to 1 mg of niacin equivalent. *Glutamine* - **Glutamine** is the most abundant amino acid in the body and plays an important role in immune function, gut health, and nitrogen transport. - While essential for many bodily functions, glutamine is not directly involved in the synthesis pathway of nicotinic acid. *Glycine* - **Glycine** is the simplest amino acid and plays important roles in protein synthesis, collagen formation, and as a neurotransmitter. - It serves as a precursor for heme, purines, and creatine, but is not involved in nicotinic acid synthesis. *Phenylalanine* - **Phenylalanine** is an essential amino acid that is a precursor for tyrosine, which in turn is a precursor for thyroid hormones, catecholamines (dopamine, norepinephrine, epinephrine), and melanin. - While it has significant metabolic roles, phenylalanine does not participate in the synthesis of nicotinic acid.

Question 1

Which branched-chain amino acid is the PRIMARY contributor to neurotoxicity in maple syrup urine disease?

Accepted Answer

Leucine

Answer

Isoleucine

Answer

Valine

Answer

Phenylalanine

Question 2

Which of the following statements about Carbamoyl Phosphate Synthetase I (CPSI) is true?

Accepted Answer

N-Acetyl Glutamate is an allosteric activator of CPSI.

Answer

It is present in the cytoplasm.

Answer

It is involved in pyrimidine synthesis.

Answer

Glutamine is the amino group donor for CPSI.

Question 3

Which enzyme catalyzes the transfer of an α-amino group from aspartate to α-ketoglutarate?

Accepted Answer

Aspartate Transaminase (AST)

Answer

Ornithine transcarbamylase (OTC)

Answer

Argininosuccinate lyase (ASL)

Answer

Alanine Aminotransferase (ALT)

Question 4

A 3-day-old newborn presents with hyperammonemia in the blood and an unknown inborn error of metabolism. What is the most likely diagnosis?

Accepted Answer

Urea cycle enzyme deficiency

Answer

Maple syrup urine disease

Answer

Organic aciduria

Answer

Phenylketonuria

Question 5

Urea is synthesized in all except:

Accepted Answer

Brain

Answer

Spleen

Answer

Liver

Answer

Kidney

Question 6

Tyrosine enters gluconeogenesis by forming which substrate

Accepted Answer

Fumarate

Answer

Succinyl CoA

Answer

Alpha-ketoglutarate

Answer

Citrate

Question 7

In argininosuccinase deficiency, what should be supplemented to continue the urea cycle ?

Accepted Answer

Arginine

Answer

Aspartate

Answer

Argininosuccinate

Answer

Citrulline

Question 8

Citrullinemia is due to deficiency of?

Accepted Answer

Argininosuccinate synthase

Answer

Arginase

Answer

Ornithine transcarbamylase

Answer

Argininosuccinate lyase

Question 9

Cabbage-like odour is seen in ?

Accepted Answer

Tyrosinemia

Answer

Alkaptonuria

Answer

Phenylketonuria

Answer

Hartnup disease

Question 10

Which amino acid is a precursor for the synthesis of nicotinic acid?

Accepted Answer

Tryptophan

Answer

Glutamine

Answer

Glycine

Answer

Phenylalanine

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?